Home » Topics » Dermatologic, BioWorld Science

Dermatologic, BioWorld Science
RSS

New retinoid-like compounds from BMS

Nov. 26, 1996

Candela laser systems approved in Japan

Nov. 22, 1996

Pharmadigm (formerly Paradigm Biosciences) reports progress on lead therapeutic

Nov. 20, 1996

Clinical results with Seragen fusion toxin in psoriasis

Nov. 19, 1996

Clinical trials with oral and topical BCX-34 in psoriasis

Nov. 15, 1996

FDA clears generic OTC product for hair regrowth

Nov. 8, 1996

Advanced Polymer Systems and Medicis sign agreement for dermatology products

Nov. 1, 1996

Hybridon researches VEGF/VPF antisense compounds for skin disorders

Nov. 1, 1996

Roche describes retinoid compounds for acne, cancer

Nov. 1, 1996

Cholestyramine treatment of peri-anal irritation in an infant

Oct. 25, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 29, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 29, 2026.
Brain-derived tau in blood predicts stroke severity and outcome
BioWorld Science
Brain-derived tau, a protein that is exclusive to the brain and detectable in the blood, could serve as an indicator of brain damage after an ischemic stroke. The...
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...
First-in-class ADC targeting DEM-TXX shows high preclinical efficacy
BioWorld Science
Researchers at DEM Biopharma Inc. reported preclinical findings demonstrating the efficacy of DEM-301, a bifunctional antibody-drug conjugate (ADC) engineered to...